Filter
472
Filtered Results: 472
Text search:
European
Center
for
Disease
Control
ECDC
Featured
Recommendations
45
New Publications
85
Language
Document type
No document type
191
Guidelines
92
Studies & Reports
83
Fact sheets
31
Manuals
21
Infographics
11
Strategic & Response Plan
10
Situation Updates
9
Resource Platforms
9
Training Material
6
Online Courses
4
Videos
3
Brochures
2
Countries / Regions
Western and Central Europe
81
Ukraine
18
Germany
18
Eastern Europe and Central Asia
17
Eastern Europe
16
Global
7
Africa
7
Brazil
6
Russia
6
Guinea
5
Latin America and the Carribbean
5
West and Central Africa
5
Madagascar
5
Sierra Leone
4
Liberia
4
Colombia
3
Nigeria
3
Mozambique
3
Congo, Democratic Republic of
3
North Macedonia
2
Albania
2
Estonia
2
Burkina Faso
2
Guinea-Bissau
2
Venezuela
2
Middle East and North Africa
2
Paraguay
2
France
2
Spain
2
East and Southern Africa
2
Romania
2
Myanmar / Burma
2
Tajikistan
1
Turkey
1
Ghana
1
Benin
1
Rwanda
1
Cameroon
1
Syria
1
Senegal
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Bulgaria
1
Italy
1
Armenia
1
Haiti
1
Asia
1
South–East Asia Region
1
Western Pacific Region
1
Turkmenistan
1
Denmark
1
Portugal
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Bangladesh
1
Moldova
1
Georgia
1
Mali
1
Angola
1
Libya
1
South Sudan
1
India
1
Authors & Publishers
Publication Years
Category
Countries
87
Clinical Guidelines
23
Key Resources
23
Public Health
12
Capacity Building
3
Women & Child Health
2
Pharmacy & Technologies
1
Toolboxes
COVID-19
98
AMR
68
Rapid Response
59
HIV
58
TB
47
Zika
27
Ebola & Marburg
24
Refugee
21
Conflict
18
Planetary Health
13
Mental Health
8
NTDs
7
Global Health Education
4
Specific Hazards
3
Cholera
3
Caregiver
2
Pharmacy
2
Natural Hazards
1
Health Financing Toolbox
1
Malaria
1
Polio
1
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3: Drug-related harms and responses
- Annex: National data tables
Available in 24 languages on:
http://www.emcdd...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-...
The main objective of this mission was to assess the level of preparedness of Guinea-Bissau in respect of the WHO consolidated checklist. The checklist helps countries to assess and test their level of readiness it is being used to identify concrete action to be taken and where countries will requir...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
Perspectives on Drugs
Mission report April 2016
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Evaluation report
December 2014
Evaluation report
September 2014
Evaluation report November 2014
In the current absence of vaccine for COVID-19, public health response target breaking the chain of infection by focusing on the mode of transmission. This paper summarizes current evidence-base around the transmission dynamics, pathogenic, and clinical features of COVID-19, to critically identify i...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re...
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of
risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the difference in yield and numbers needed to screen (NNS) by c...
